🇺🇸 FDA
Patent

US 6485722

Method for selective engraftment of drug-resistant hematopoietic stem cells

expired A61KA61K2035/124A61K48/00

Quick answer

US patent 6485722 (Method for selective engraftment of drug-resistant hematopoietic stem cells) held by Regents of the University of Minnesota expires Mon Nov 21 2022 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Regents of the University of Minnesota
Grant date
Tue Nov 26 2002 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 21 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
34
CPC classes
A61K, A61K2035/124, A61K48/00